Department of Orthopaedics, University of Utah, 590 Wakara Way, Salt Lake City, UT, 84108, USA,
Clin Orthop Relat Res. 2013 Dec;471(12):4076-81. doi: 10.1007/s11999-013-3232-z. Epub 2013 Aug 17.
The current mainstay of orthopaedic pain control is opioid analgesics but there are few studies in the literature evaluating the effects of opioids on bone healing.
QUESTIONS/PURPOSES: The purpose of this study was to use a rat fracture model to evaluate the effects of opioid administration on osseous union in the acute (4 weeks) and subacute (8 weeks) setting in an operatively stabilized fracture. We asked the following question: does morphine administration alter (1) fracture callus strength; (2) callus volume and formation; and (3) morphology and early remodeling to final osseous union?
A 0.4-mm femoral osteotomy gap was created in 50 Sprague-Dawley rats using an established model. Postoperatively, rats were randomized to control versus morphine-treated study groups. Equal numbers of rats from each group were euthanized at 4 weeks and 8 weeks postoperatively. Three-point bend biomechanical testing was performed to evaluate postoperative callus strength. Micro-CT scans and histological analyses were used to evaluate postoperative callus volume and formation, morphology, and features of early remodeling.
Biomechanical testing identified a statistically significant (p = 0.048) reduction in callus strength in morphine-treated animals 8 weeks postoperatively compared with controls. Radiographic and histological analysis showed delayed callus maturation and lack of remodeling in the morphine group compared with control animals at 8 weeks. Micro-CT analysis expressed remodeling and resorption as a decrease in callus volume over the two time points. The control group had significant levels of resorption decreasing 29% (p = 0.023) over the 4-week to 8-week time interval. Morphine administration inhibited callus resorption and remodeling with only a 13% decrease (p = 0.393) in callus volume comparing these time points. The callus inhibition associated with morphine administration was not as evident in the acute, 4-week time setting.
Morphine administration inhibited callus strength in this animal model. This finding is likely consistent with the observation that the callus and healing bone appear to have a decreased rate of maturation and remodeling seen at 8 weeks.
This study identifies that administration of an opioid pain medication leads to weaker callus and impedes callus maturation compared with controls. These findings may provide the impetus to alter our current orthopaedic analgesic gold standard toward more multimodal and opioid-limiting pain control regimens.
目前骨科疼痛控制的主要手段是阿片类镇痛药,但文献中很少有研究评估阿片类药物对骨愈合的影响。
问题/目的:本研究旨在使用大鼠骨折模型评估阿片类药物在手术稳定骨折的急性(4 周)和亚急性(8 周)环境中对骨愈合的影响。我们提出了以下问题:吗啡给药是否会改变(1)骨折骨痂强度;(2)骨痂体积和形成;和(3)形态和早期重塑以达到最终的骨性愈合?
使用已建立的模型在 50 只 Sprague-Dawley 大鼠中创建 0.4mm 股骨骨切开间隙。手术后,大鼠随机分为对照组和吗啡治疗组。每组的等量大鼠在术后 4 周和 8 周时处死。三点弯曲生物力学测试用于评估术后骨痂强度。微 CT 扫描和组织学分析用于评估术后骨痂体积和形成、形态以及早期重塑的特征。
生物力学测试表明,吗啡治疗组大鼠术后 8 周时骨痂强度有统计学意义的降低(p = 0.048)。与对照组相比,放射学和组织学分析显示吗啡组在 8 周时骨痂成熟延迟且缺乏重塑。微 CT 分析表示重塑和吸收表现为两个时间点上骨痂体积的减少。对照组在 4 周到 8 周的时间间隔内,吸收量显著减少了 29%(p = 0.023)。吗啡给药抑制骨痂吸收和重塑,仅使骨痂体积减少 13%(p = 0.393)。在急性 4 周时间设置中,与吗啡给药相关的骨痂抑制并不明显。
吗啡给药抑制了该动物模型中的骨痂强度。这一发现可能与以下观察结果一致,即骨痂和愈合骨似乎表现出成熟和重塑速度减慢,这在 8 周时可见。
本研究表明,与对照组相比,阿片类药物的给药会导致骨痂变弱,并阻碍骨痂成熟。这些发现可能为改变我们目前的骨科镇痛金标准提供动力,转向更多的多模式和阿片类药物限制的疼痛控制方案。